Puma Biotechnology, Inc.
PBYI
$8.83
$0.121.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.19M | -3.75M | 13.44M | 8.84M | 5.86M |
| Total Depreciation and Amortization | 2.52M | 2.58M | 1.86M | 2.72M | 2.76M |
| Total Amortization of Deferred Charges | -- | -- | 800.00K | -- | -- |
| Total Other Non-Cash Items | 1.95M | 1.90M | 4.86M | 1.46M | 1.27M |
| Change in Net Operating Assets | -11.03M | 14.68M | -6.54M | -3.34M | 4.20M |
| Cash from Operations | 1.62M | 15.42M | 14.42M | 9.69M | 14.08M |
| Capital Expenditure | -- | -- | 36.00K | -26.00K | -20.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.97M | 2.47M | -27.01M | 532.00K | -11.23M |
| Cash from Investing | 7.97M | 2.47M | -26.98M | 506.00K | -11.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.12M | -11.11M | -11.11M | -11.11M | -11.11M |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 130.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -223.00K | -222.00K | -222.00K | -222.00K | -222.00K |
| Cash from Financing | -11.34M | -11.33M | -11.33M | -11.33M | -11.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.75M | 6.56M | -23.89M | -1.14M | -8.37M |